Tim Loh
-
Sanofi’s Chronic Lung Disease Drug Gets EU Regulator Backing
If approved, Sanofi's Dupixent will be the first-ever targeted therapy for the disease in the EU.
- Friday May 31, 2024
- Author: Tim Loh
-
Bayer’s New CEO to Cut Management Jobs in Bid for Turnaround
Bayer AG said it has agreed with employee groups on a plan to cut a “significant” number of jobs as the company looks to streamline operations and improve its performance.
- Thursday January 18, 2024
- Author: Tim Loh
-
Bayer’s New CEO to Cut Management Jobs in Bid for Turnaround
Bayer AG said it has agreed with employee groups on a plan to cut a “significant” number of jobs as the company looks to streamline operations and improve its performance.
- Thursday January 18, 2024
- Author: Tim Loh
-
Bayer Says It Didn’t Know About Study Results Before Bond Sale
Bayer AG said it didn’t know the results of its blood-thinner drug trial, which was halted this week due to a lack of efficacy, before selling $5.75 billion of bonds to investors.
- Friday November 24, 2023
- Author: Ronan Martin, Tim Loh
-
Roger Federer-Backed Shoemaker On Sees Sales Surge
Swiss shoemaker On Holding AG reported earnings that topped estimates amid fast growth in US sneaker sales.
- Tuesday November 14, 2023
- Author: Tim Loh
-
Sanofi CEO Shocks Investors With Investment Plan, Few Details
When the day began, Paul Hudson, Sanofi’s perennially upbeat chief executive officer, was sitting pretty with a double-digit share gain this year, a world-beating drug in Dupixent and few of the patent cliff worries weighing on his big pharma rivals.
- Monday October 30, 2023
- Author: Tim Loh
-
Adidas Rises After Boosting Guidance Again On Yeezy Sales
The stock climbed as much as 5.3% in early German trading. It’s up about 40% this year.
- Wednesday October 18, 2023
- Author: Tim Loh
-
Federer-Backed Shoemaker On Plots Fast Growth In Bid To Rival Nike, Adidas
Swiss shoemaker On Holding AG plans to double sales to 3.55 billion Swiss francs ($3.85 billion) by 2026, targeting fast growth in China, as it seeks to become the world’s “most premium” sportswear brand.
- Wednesday October 4, 2023
- Author: Tim Loh
-
Europe Warns of New, Highly Mutated Covid Strain as Cases Rise
European health officials warned that the new, highly mutated Pirola coronavirus variant is circulating on the continent and may be behind an uptick in Covid-19 cases.
- Monday September 11, 2023
- Author: Tim Loh
-
Europe Warns of New, Highly Mutated Covid Strain as Cases Rise
European health officials warned that the new, highly mutated Pirola coronavirus variant is circulating on the continent and may be behind an uptick in Covid-19 cases.
- Monday September 11, 2023
- Author: Tim Loh
-
Nike, Adidas Bet Big On World Cup Football Shirts And Merch
For this year’s Women’s World Cup, the stakes are particularly high. This is the first time the tournament has featured 32 teams and the prize money is triple what it was in 2019.
- Thursday August 17, 2023
- Author: Tim Loh
-
Nike, Adidas Bet Big On World Cup Football Shirts And Merch
For this year’s Women’s World Cup, the stakes are particularly high. This is the first time the tournament has featured 32 teams and the prize money is triple what it was in 2019.
- Thursday August 17, 2023
- Author: Tim Loh
-
Bayer Cuts 2023 Outlook Amid Slump in Prices for Roundup
Bayer AG cut its outlook for the year amid persistently low prices for agriculture products, including the controversial weedkiller Roundup.
- Tuesday July 25, 2023
- Author: Tim Loh
-
Adidas Sees Losses Narrowing After Selling Some Yeezy Shoes
Adidas AG improved its guidance for the year after starting to sell its inventory of Yeezy sneakers from a canceled partnership with the rapper and designer Kanye West.
- Tuesday July 25, 2023
- Author: Tim Loh
-
Adidas Sees Losses Narrowing After Selling Some Yeezy Shoes
Adidas AG improved its guidance for the year after starting to sell its inventory of Yeezy sneakers from a canceled partnership with the rapper and designer Kanye West.
- Tuesday July 25, 2023
- Author: Tim Loh